Isracann Biosciences Management
Management criteria checks 0/4
We currently do not have sufficient information about the CEO.
Key information
Ajay Kaila
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 1.7yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | no data |
Recent management updates
Recent updates
CEO
Ajay Kaila
1.7yrs
Tenure
Ajay Singh Kaila is Interim Chief Executive Officer of Isracann Biosciences Inc. from January 20, 2023.